Skip to main content
Premium Trial:

Request an Annual Quote

Pistoia Alliance Selects Projects for Second Phase of Sequence Analysis Program

Premium

The Pistoia Alliance has selected three projects for the second phase of its sequence-services program, which aims to build a fully functional platform for analyzing and storing next-generation sequencing data.

The goal of the project, which launched in July, is to develop a sequence analysis platform that uses open source tools and is both secure and scalable (BI 7/29/2011).

The winning entries, which were selected from a field of 10 proposals, came from Constellation and GeneStack; Eagle Genomics and Cycle Computing; and Hewlett-Packard.

The groups are expected to present a proof-of-concept system at the annual Pistoia Alliance Conference that will be held on April 24 in Boston.

A commercial release of the platform is expected by mid-2012.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.